Microbiome Therapies Threatened by Covid-19 Restrictions
Providers of microbiome therapies worldwide have been hit by pandemic restrictions on the harvest of…
Providers of microbiome therapies worldwide have been hit by pandemic restrictions on the harvest of…
Update on 29/07/2020: DNA Script has increased the total raised in its Series B round…
A fungicide derived from amoeba has proven effective at protecting wheat from rust disease and…
Osivax, a Lyon-based biotechnology company, secured €17.5M from the European Innovation Council and €15.1M from…
The French startup Phost’in Therapeutics has raised €10.3M to take its cancer immunotherapy drug against…
The French clinical diagnostics specialist Novacyt has announced FDA authorization for its fast and easily…
French biotech DBV Technologies’ bid for the US approval of a skin patch to treat…
The French company Sensorion has been forced to delay a phase II trial in people…
French researchers have found that the levels of certain immune cells in the blood of…
A drug developed by the French company MedDay Pharmaceuticals has failed to treat progressive forms…
Update (11/03/2020): In a record first, Carmat announced today that one patient in its artificial…
Scipio bioscience has raised €6M in a Series A round to launch cost-effective single-cell RNA…